Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of rLH/rFSH Protocols in Hypogonadotropic Hypogonadism
NCT02140515Phase 4Unknown
- Sponsor
- Royan Institute
- Start
- Nov 2012
- Primary completion
- Dec 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of lutropin alfa in hypogonadotropic hypogonadism (HH), sponsored by Royan Institute. Status: unknown.
02
Drugs
lutropin alfa
03
Conditions
hypogonadotropic hypogonadism (HH)
Beyond the preview
Go deeper on NCT02140515.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02140515.